Disposable Infusion Sets Market Size, Demand & Growth by 2034
Coverage: By Product (Pump Infusion Set, Non-pump Infusion Set); Material (Polyvinyl Chloride (PVC), Polyolefins, Nitroglycerin, Others); End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)
- Status : Data Released
- Report Code : TIPRE00018044
- Category : Life Sciences
- No. of Pages : 150
- Available Report Formats :

- Last update date : June 23, 2026
2025 Market Size
US$ 1.12 Bn
Base year value
2034 Forecast
US$ 1.59 Bn
Projected by 2034
CAGR 2026-2034
4.03 %
Growth rate
Addressable Market
US$ 12.35 Bn
(2026-2034)
The global disposable infusion sets market size is projected to reach US$ 1.59 billion by 2034 from US$ 1.12 billion in 2025. The market is anticipated to register a CAGR of 4.03% during the forecast period 2026–2034.
Key market dynamics include a rising geriatric population requiring intravenous therapies, the increasing prevalence of chronic diseases necessitating frequent infusions, and a growing emphasis on minimizing hospital-acquired infections. Additionally, the market is expected to benefit from the expansion of ambulatory surgical centers, the rapid adoption of home-based healthcare models, and continuous technological advancements in filter materials and needleless connector designs that enhance patient safety and delivery precision.
Disposable Infusion Sets Market Analysis
The disposable infusion sets market analysis indicates a significant shift toward precision drug delivery and infection control. The market trends show a transition from traditional gravity-led sets to advanced pump-compatible and secondary sets as hospitals prioritize medication error reduction. Strategic opportunities are emerging in the home infusion sector, where the rise of telehealth and remote monitoring allows for complex treatments, such as oncology and parenteral nutrition, to be administered outside traditional hospital settings. The market expansion is increasingly reliant on material innovation, specifically the move toward non-PVC and DEHP-free materials to meet stringent safety and environmental regulations. Competitive differentiation is now defined by the integration of safety features like anti-siphon valves and precise filtering technologies, allowing leading manufacturers to maintain premium pricing in an otherwise fragmented landscape.
Disposable Infusion Sets Market Overview
Infusion therapy has evolved from a standard hospital procedure to a critical component of modern chronic disease management. The disposable infusion sets include high-precision filtering sets, needleless connectors, and specialized subcutaneous sets for insulin and immunoglobulin delivery. Both global med-tech giants and regional manufacturers compete in this market, focusing on optimizing fluid path integrity and reducing the risk of air embolism. Growing demand for portable and user-friendly infusion solutions among health-conscious patients in North America and Europe has increased the popularity of ambulatory sets. North America leads in revenue due to its established infrastructure and high surgical volume, while Asia-Pacific is advancing rapidly due to healthcare infrastructure modernization and rising disposable incomes. The US market is a mature landscape characterized by a high prevalence of chronic conditions and an established transition toward outpatient care. Demand is propelled by a shift to home-based services and ambulatory centers, supported by favorable reimbursement and a strong regulatory emphasis on needleless safety and non-PVC materials.
Market Assessment and Insights
- Global market for Disposable Infusion Sets was valued at US$ 1.12 Billion in 2025
- Annual market size is expected to reach US$ 1.59 Billion by 2034
- Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 12.35 Billion
- Market is anticipated to register a CAGR of 4.03% during the forecast period
- The United States represents a key market, supported by Rising Prevalence of Chronic Diseases, Growing Preference for Home Healthcare, Advancements in Infusion Technolog, as well as evolving industry dynamics
- Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
- Market opportunities such as Expansion in Home Healthcare Market, Growing Demand for Pain Management Infusions, Development of Customizable Infusion System are expected to influence market dynamics and addressable market
- Report profiles industry participants, including NIPRO Corporation, Micsafe Medical Group, Fresenius Kabi Ltd, Bexen Medical, CardioMed Supplies Inc., Neomedic Limited, Van Oostveen Medical B.V., Zhejiang Kindly Medical Devices Co., Ltd., Smith Medical, Zhejiang Jinghuan Medical Apparatus Co.,Ltd., while analyzing competitive strategies and innovation developments
-
Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.
● REPORT CUSTOMIZATION
Tailor This Report To Align With Your Specific Business Requirements
This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.
Customize This Report →WHAT YOU CAN ADJUST
- ● Segmentations
- ● Geography
- ● Competitive Analysis
- ● Language Preferences
Disposable Infusion Sets Market: Strategic Insights
-
Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Disposable Infusion Sets Market Drivers and Opportunities
Market Drivers:
- Superior Safety and Infection Prevention: Single-use infusion sets eliminate the risk of cross-contamination and are central to hospital initiatives focused on reducing catheter-related bloodstream infections.
- Advancements in Material Science: The transition to polyolefin and other specialized polymers ensures better drug compatibility, particularly for sensitive medications that may react with standard plastics.
- Rise in Chronic Disease Management: Increasing global cases of cancer, autoimmune disorders, and diabetes require consistent, high-volume use of disposable infusion supplies for both acute and long-term care.
Market Opportunities:
- Expansion into Pediatric and Geriatric Nutrition: Specialized disposable sets for parenteral nutrition offer high growth potential as clinicians seek more precise delivery systems for vulnerable populations.
- Growth in Ambulatory and Home-Care Segments: Designing easy-to-use, fool-proof infusion sets for non-clinical environments represents a significant opportunity as healthcare shifts away from traditional hospital stays.
- Regional Infrastructure Modernization in APAC: Building partnerships with emerging public and private hospital networks in China and India provides a gateway to high-volume recurring revenue.
Disposable Infusion Sets Market Report Segmentation Analysis
The Disposable Infusion Sets Market share is analyzed across various segments to provide a clearer understanding of its structure, growth potential, and emerging trends. Below is the standard segmentation approach used in most industry reports:
By Product:
- Pump Infusion Set: A high-growth segment designed for use with electronic or elastomeric pumps, ensuring highly accurate delivery of fluids and medications.
- Non-pump Infusion Set: The dominant volume driver, primarily utilizing gravity to deliver standard saline, glucose, and non-critical medications in various care settings.
By Material:
- Polyvinyl Chloride (PVC): Traditionally, the most common material due to its flexibility and low cost, though it is seeing a gradual decline in highly regulated markets.
- Polyolefins: A rapidly expanding alternative preferred for being DEHP-free and offering superior chemical resistance for a wide range of drug formulations.
- Nitroglycerin: Specialized tubing materials designed specifically to prevent the absorption of nitroglycerin and other lipid-soluble drugs into the tube walls.
- Others: Includes various medical-grade elastomers and advanced polymer blends designed for extreme durability or specific drug-shielding properties.
By End User:
- Hospitals & Clinics: Remains the primary end user, accounting for the largest market share due to the high volume of daily inpatient procedures and surgeries.
- Ambulatory Surgical Centers: A fast-rising channel as more surgical procedures shift to outpatient environments that prioritize high-throughput and sterile disposables.
- Others: Includes home care settings, nursing homes, and diagnostic centers, where the demand for portable and simplified infusion solutions is accelerating.
By Geography:
- North America
- Europe
- Asia Pacific
- South & Central America
- Middle East & Africa
Disposable Infusion Sets Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2025 | US$ 1.12 Billion |
| Market Size by 2034 | US$ 1.59 Billion |
| Global CAGR (2026 - 2034) | 4.03% |
| Historical Data | 2021-2024 |
| Forecast period | 2026-2034 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
Disposable Infusion Sets Market Players Density: Understanding Its Impact on Business Dynamics
The Disposable Infusion Sets Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Disposable Infusion Sets Market Share Analysis by Geography
Asia-Pacific is expected to grow fastest in the coming years. Emerging markets in South & Central America, the Middle East, and Africa also have many untapped opportunities for medical device manufacturers and healthcare providers to expand.
The disposable infusion sets market is undergoing a significant transformation, moving from basic gravity-fed administration to high-precision, safety-engineered delivery systems. Growth is driven by the rising prevalence of chronic diseases, a surge in outpatient surgical procedures, and the expansion of the home healthcare sector. Below is a summary of market share and trends by region:
North America
- Market Share: Holds the largest share globally, driven by advanced healthcare infrastructure and a highly developed reimbursement landscape.
- Key Drivers:
- High volume of surgical procedures and inpatient treatments in the US and Canada.
- Rapid mainstreaming of smart infusion technologies and safety-engineered needleless connectors.
- Stringent regulatory focus from the FDA on infection control and reducing medication errors.
- Trends: Scaling of home infusion services for oncology and clinical nutrition, alongside a successful transition to DEHP-free and PVC-free materials to meet health safety standards.
Europe
- Market Share: A dominant segment anchored by robust public healthcare systems and strict medical device safety directives in Germany, France, and the UK.
- Key Drivers:
- Increasing adoption of specialty infusion sets for pain management and pediatric care.
- Established processing infrastructure and standardized clinical protocols for intravenous therapy.
- Strong government support for sustainable medical waste management and green procurement.
- Trends: A strategic shift toward prioritizing pump-compatible sets for high-margin intensive care units. There is also an increasing focus on integrated drug library systems to enhance patient safety.
Asia-Pacific
- Market Share: The fastest-growing region, with China and India acting as primary markets for market volume due to massive population bases.
- Key Drivers:
- Rapid expansion of tertiary care hospitals and ambulatory surgical centers in urban centers.
- Government-supported healthcare initiatives focused on improving access to life-saving IV therapies.
- Rising disposable incomes leading to a preference for premium, safety-engineered medical disposables.
- Trends: Heavy reliance on local manufacturing partnerships and B2B contracts for high-volume supply, coupled with a focus on tiered product portfolios to balance affordability and advanced features.
South and Central America
- Market Share: Emerging market with a growing private hospital in countries like Brazil and Chile.
- Key Drivers:
- Increasing awareness of hospital-acquired infection (HAI) prevention protocols.
- Modernization of existing hospital facilities to include commercial-grade infusion technologies.
- Rising interest in home-based treatment for chronic conditions like diabetes and heart disease.
- Trends: Growth of decentralized care models and the introduction of specialized extension lines to differentiate from standard bovine-based or legacy gravity sets.
Middle East and Africa
- Market Share: Developing market with significant investments in healthcare modernization, particularly in the GCC region.
- Key Drivers:
- Strategic investments in smart hospitals to improve local healthcare security and quality of care.
- High demand for shelf-stable and durable medical disposables in diverse clinical climates.
- Transition from informal procurement to formalized commercial medical supply chains.
- Trends: Implementation of modern milking-refrigeration-style cold chain logic for temperature-sensitive infusions and a focus on high-precision pediatric sets.
High Market Density and Competition
Competition is intensifying due to the presence of established leaders such as Becton Dickinson and Company (BD), B. Braun SE, and Baxter International Inc. Regional experts and niche players also contribute to a diverse and rapidly expanding market landscape.
This competitive environment pushes vendors to differentiate through:
- Safety-First Design: Integrating needleless connectors and anti-free-flow valves to prevent medication errors and healthcare worker injuries.
- Drug-Specific Engineering: Developing sets with specialized linings (such as nitroglycerin-compliant tubing) to ensure drug efficacy and patient safety.
- Operational Efficiency: Providing pre-packaged, standardized kits that reduce nursing workload and streamline hospital inventory management.
Opportunities and Strategic Moves
- Partner with digital health firms to create connected infusion sets that can monitor flow rates and provide data-driven insights for home-care patients.
- Focus on sustainable manufacturing by utilizing recyclable materials and reducing packaging waste to align with global green healthcare initiatives.
Major Companies operating in the Disposable Infusion Sets Market are:
- NIPRO Corporation
- Micsafe Medical Group
- Fresenius Kabi Ltd
- Bexen Medical
- CardioMed Supplies Inc.
- Neomedic Limited
- Van Oostveen Medical B.V.
- Zhejiang Kindly Medical Devices Co., Ltd.
- Smith Medical
- Zhejiang Jinghuan Medical Apparatus Co., Ltd.
Disclaimer: The companies listed above are not ranked in any particular order.
Disposable Infusion Sets Market News and Recent Developments
- In December 2025, InfuSystem Holdings, Inc. announced that the Centers for Medicare and Medicaid Services (“CMS”) had added two of the electronic infusion pumps currently utilized by the Company within its Pain Management services business to the list of qualifying products for separate payment in conjunction with the Non-Opioids Prevent Addiction in the Nation (“NOPAIN”) Act. The NOPAIN Act mandates that CMS provide separate payment for qualified non-opioid treatments through December 31, 2027, when provided with a covered surgical procedure. This payment may now be available to InfuSystem’s current and potential Pain Management customers for certain patients. This initiative is part of a broader strategy by CMS to combat the opioid crisis by promoting safer pain management alternatives. The two pumps are the CADD-Solis™ manufactured by ICU Medical, Inc., and Eitan Medical’s Sapphire™ pump.
- In April 2025, ICU Medical Inc. announced 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Plum Solo™ precision IV pump, a single-channel complement to the dual-channel Plum Duo™. ICU Medical also received 510(k) clearance for updated versions of the Plum Duo precision IV pump and LifeShield™ infusion safety software, completing the initial launch of the ICU Medical IV Performance Platform. With these FDA clearances, ICU Medical is introducing its new category of precision IV pumps and expanding the ICU Medical IV Performance Platform.
Disposable Infusion Sets Market Report Coverage and Deliverables
The Disposable Infusion Sets Market Size and Forecast (2021–2034) report provides a detailed analysis of the market covering below areas:
Disposable Infusion Sets Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Disposable Infusion Sets Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Disposable Infusion Sets Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the Disposable Infusion Sets Market.
- Detailed company profiles
Frequently Asked Questions
Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.
Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.
- Comprehensive Market Sizing and Forecast Analysis
- Detailed Segmentation Analysis
- In-Depth Market Dynamics Assessment
- Regional and Country-Level Insights
- Competitive Landscape and Company Benchmarking
- Strategic Business Intelligence
Recent Reports
Testimonials
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDsI requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future AnalyticaWe worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam GlobalThe Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK TechnologiesI wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends